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Abstract
Based on principles specified in the Swedish Code on health claims and experiences from handling of claims
within the Code, priorities that may be useful when establishing a positive list of generic health claims and for
responsible use of claims are suggested. One key factor highlighted is that claims should be relevant and
meaningful for the consumer. To be useful in choosing a healthy diet, claims should primarily aim to stimulate
an intake in agreement with official nutrition recommendations. Claims may thus be considered as relevant
primarily for nutrients of which a considerable part of the population has an intake deviating from the
recommendations. For vitamins and minerals, commonly involved in many functions in the body, it would be
useful to prioritize claims referring to effects considered more important than others. Functions true for all
essential nutrients, and/or affected by a large number of dietary factors, would be less relevant to claim for
single vitamins and minerals. The relative importance of a specific vitamin or mineral, in relation to other
nutrients potentially exerting similar effects, should also be considered. Based on these priorities, and on
claims permitted or suggested as examples in the Code, a list of generic claims on vitamins, minerals, fatty
acids, carbohydrates, dietary fibre, energy and wholegrain is suggested. Additional issues considered within
the Code are also discussed.
Keywords: generic; glycaemic index; meaningful; relevant
Introduction
H
ealth claims on foods have recently been
regulated in the European Union (EU), by
‘‘Regulation (EC) no 1924/2006 of the
European Parliament and of the Council of 20 De-
cember 2006 on nutrition and health claims made
on foods’’ (hereafter referred to as the Regulation)
(1, 2). According to Article 13.3 of the Regulation,
the European Commission (COM) will establish a
positive list of claims other than those referring to
the reduction of disease or to children’s develop-
ment and health, i.e. Article 13 claims (hereafter
referred to as the Article 13.1 list). The Article 13.1
list will be established by 31 January 2010 after
consulting the European Food Safety Authority
(EFSA). All claims in the Article 13.1 list may be
used without any further application or notification
procedure, provided that the claim and product
comply with the Regulation and any conditions of
use specified for the claim in question, including the
nutrient profiles to be established. The competent
authorities (CA) in all Member States, in Sweden
the National Food Administration (NFA), can
submit suggestions to the COM by 19 January
2008 (1; Article 13.2). In addition to the positive list
of authorized claims that will be included in the
Community Register a list of rejected claims will be
established.
The exact procedure for how the CAs will act to
collect national suggestions for Article 13.1 claims is
not specified by the Regulation. Some Member
States, e.g. Finland (3) and the UK (4), have
collected claims used on the market or made open
calls for suggestions. Extensive lists of claims have
also been compiled by various organizations. For
example, the Confederation of the Food and Drink
Industries in the EU (CIAA) (5) recently published
a list of 759 claims, including claims for nutrients,
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and botanicals (e.g. herbs and spices, and parts of or
extracts from such foods).
In Sweden the NFA has invited two organizations
for co-ordinating the proposal from the food
industry on health claims according to Article 13.1.
As the co-ordinating body within the Swedish Food
Sector’s Code of Practice on health claims (see
below), SNF Swedish Nutrition Foundation (6) will
suggest claims applicable to regular foods, while the
Swedish food supplement producer’s association
(Svensk Egenva ˚rd) (7) will co-ordinate health claims
related to food supplements. NFA will also accept
proposals for health claims submitted by other food
business operators, but recommends that other
operators first consult these two organizations, e.g.
regarding the level of scientific evidence that can be
assumed to be required.
In Sweden claims will be submitted to NFA by
30 September 2007. Before a national list is sub-
mitted to the COM, NFA will, among other things,
consult the Medicinal Products Agency regarding
claims on the borderline between health claims and
medicinal claims. The final list will be established by
COM, after a scientific evaluation made by EFSA
(1, 2).
The Swedish Code in relation to the Regulation
The Swedish Code ‘‘Health Claims in the Labelling
and Marketing of Food Products. The Food Sector’s
Code of Practice’’ (hereafter referred to as the
Code) was introduced in 1990 (8). SNF Swedish
Nutrition Foundation has been the co-ordinating
body within the Code since its introduction. Princi-
pals of the Code are the Swedish Food Federation
and the Swedish Food Retailers Federation.
The Code is applicable to regular foods,b u t
explicitly not to supplements and other foods
appearing as medicinal products, e.g. in the form
of capsules and pills. The Regulation, in contrast, is
applicable also to food supplements. Furthermore,
claims according to the Code are limited to foods
contributing to a nutritionally balanced diet, and
nutritional profiles are defined in the 2004 version
(8, 9), with a general reference to the NFA’s
regulation on the use of a particular symbol, i.e.
the keyhole symbol (10). Within the Regulation,
nutritional profiles will be established by the COM
by 19 January 2009 (1, Article 4).
Three categories of health claims are defined by
the Code: generic nutrient function claims, generic
reduction of disease risk claims (nine allowed con-
nections) and product-specific physiological claims
(abbreviated to PFP in Swedish) (8). The Regulation
does not explicitly classify health claims into generic
and product-specific claims, but Article 13 claims
based on ‘‘generally accepted scientific evidence’’
(Article 13.1 claims) could be assumed to be pri-
marily generic, while the use of those based on
‘‘newly developed scientific evidence’’, i.e. innova-
tive claims (Article 13.5) may be limited to certain
food products or food categories. However, the
exact delimitation between Articles 13.1 and 13.5
is not yet clear. Therefore, in addition to the generic
claims in the SNF list in focus here (Table 1),
product-specific claims evaluated and approved
within the Code will be proposed by SNF for the
Article 13.1 list.
The SNF list of generic claims
Based on approved claims, examples of claims and
principles specified in the Code, a list of generic
Article 13.1 claims has been compiled (hereafter
referred to as the SNF list) (Table 1). Since the Code
allows generic claims for nutrients, energy and
wholegrain only, the SNF list primarily includes
such claims. Generic claims for other substances
than nutrients, e.g. lycopene, and botanicals are not
included, since no such health claims have been
evaluated within the Code.
Reworded reduction of disease risk claims
Reduction of disease risk claims, approved within
the Code, would by definition fall under Article 14,
for which a specific application and full evaluation
is required (11). However, similarly to nutrient
function claims, these claims are based on generally
accepted knowledge, in fact the same body of
scientific evidence that is behind the general nutri-
tion recommendations nationally and internation-
ally. Since listing of such claims is not an option at
present, another possibility suggested by SNF
would be to reword these claims in terms of
maintenance and promotion of health rather than
reduction of disease risk. For example, ‘‘reduction
of risk of osteoporosis’’ in relation to the calcium
content of foods, would correspond to ‘‘mainte-
nance/promotion of healthy/strong bones’’. Within
the UK Joint Health Claims Initiative (JHCI),
wording in terms of ‘‘healthy heart’’ and ‘‘helps
maintain heart health’’ has been used to avoid direct
reference to disease (12).
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a
No.
Suggested
classification
b Food/food component Health relationship Example of wording
c
Vitamins
1 13.1a Thiamin Nerve function Thiamin is necessary for normal function of the nerve system
2 13.1a Folate/folic acid Foetal development/
pregnancy outcome
Folate/folic acid is necessary for normal growth of the foetus/unborn
baby/Folate/folic acid is necessary for normal pregnancy outcome
3 13.1a Folate/folic acid Blood formation Folate/folic acid is necessary for normal formation of red blood cells
4 13.1a Vitamin B12 Blood formation Vitamin B12 is necessary for normal formation of red blood cells. People
eating only plant foods may have a low intake of vitamin B12
5 13.1a Vitamin B12 Nerve function Vitamin B12 is necessary for normal function of the nerve system. People
eating only plant foods may have a low intake of vitamin B12
6 13.1a Vitamin C Iron absorption/blood
formation
Vitamin C in a meal helps iron uptake, and thereby contributes red blood
cell formation
7 13.1a Vitamin D Calcium absorption/bone
health
Vitamin D is necessary for calcium uptake, and is thereby important for the
normal structure of bone
Minerals
8 13.1a Calcium Bone health Calcium is necessary for the normal structure of bone
9 13.1a Iodine Thyroid function Iodine is necessary for normal thyroid function/normal production of
thyroid hormones, and thereby contributes to normal metabolism
10 13.1a Iron Blood formation Iron is necessary for the formation of red blood cells
11 13.1a Potassium
d Blood pressure Potassium may help to maintain a healthy low blood pressure
12 13.1a Selenium Antioxidant function Selenium is necessary for antioxidative functions in the cell
13 13.1a Sodium/salt Blood pressure A diet low in salt may help to maintain a healthy low blood pressure
Macronutrients
14 13.1a Fatty acids: hard/saturated Cholesterol levels A diet low in hard fat/saturated fatty acids may help to maintain healthy
cholesterol levels in the blood
15 13.1a Fatty acids: hard/saturated Heart health A diet low in hard fat/saturated fatty acids may help to maintain a healthy
heart
16 13.1a Fatty acids: long-chain omega-3 from
fish
Heart health A diet high in omega-3 fatty acids from fish may help to maintain a healthy
heart
17 13.1a Dietary fibre Bowel regularity Dietary fibre helps to maintain bowel regularity
18 13.1a Soluble dietary fibre (beta-glucan)
from oats and barley
Cholesterol levels A diet high in soluble fibre (beta-glucan) from oats/barley may help to
maintain healthy cholesterol levels in the blood
19 13.1a Soluble dietary fibre (beta-glucan)
from oats and barley
Heart health A diet high in soluble fibre (beta-glucan) from oat/barley may help to
maintain a healthy heart
20 13.1a Carbohydrates in pasta products
e Blood glucose response Carbohydrates in pasta products provide a low and slow blood sugar
response/have a low glycaemic index (GI)
21 13.1a Carbohydrates in products other
than pasta
f
Blood glucose response Foods with a low glycaemic index (GI) give a low and slow blood glucose
response
Others
22 13.1c Energy Body weight Foods with a reduced energy content may help to maintain a healthy body
weight/A diet with reduced energy content may contribute to a lower
body weight
23 13.1a Products free from carbohydrates
fermentable by caries bacteria
Dental health Foods free from sugar(s) and other carbohydrates broken down by
bacteria in the mouth may help to maintain healthy teeth
24 13.1a Wholegrain Heart health A healthy lifestyle and a well-balanced diet high in wholegrain may
contribute to maintaining a healthy heart
aConditions of use as specified by the Code. See (8) Appendix 1 (claims no 111 and 20) and Appendix 2 (claims no 1319 and 2224). For claim no. 21, see ref. (8), Box 1.
b13.1a and 13.1c as defined by Article 13.1 of the Regulation (1). Claim nos 68, 10 and 12 are given as examples in the Code; see ref. (8), Appendix 1.
cThe examples aim to illustrate how claims might be worded. Type of wording allowed will be decided within the Regulation.
dAn upper level for the content of sodium is expected to be included in the nutrient profiles, to be established (1, Article 4).
eNot applicable to autoclaved pasta products.
fConditions of use as specified by the Code; see ref. (8), Box 1.
Article 13: priorities with reference to the Swedish Code
129Focusing on relevance
Important delimitations for the SNF list are given
by two basic principles of the Code, namely that
allowed health claims shall (i) be consistent with
official Swedish Nutrition Recommendations and
(ii) refer to functions relevant for Swedish consu-
mers.
In the Regulation the matter of relevance is not
explicitly highlighted, and it is therefore not known
to what extent this factor will be considered when
EFSA evaluates the health claims. However, it is
stated that wording and presentation of health
claims should be taken into account in the opinion
of the EFSA and in subsequent procedures, to
ensure that the claims are ‘‘truthful, clear, reliable
and useful for the consumer in choosing a healthy
diet’’ (1; clause 29). Possibly, ‘‘useful’’ may
be interpreted as ‘‘meaningful’’ as indicated in the
Swedish translation of the Regulation. In the EFSA
guidance for the application for authorization of a
health claim it is stressed that the evidence used to
support a claim should demonstrate the extent to
which the claimed effect of the food/constituent is
relevant for human health (11, p. 5).
Although there are worldwide guidelines on
nutrition and health claims (13), there are no official
agreements, nationally or internationally, as to how
to define a relevant and meaningful claim. Accord-
ing to the Regulation, health claims must be
scientifically substantiated and understandable by
the average consumer. To be useful in choosing a
healthy diet, it is suggested that claims should also
aim to stimulate an intake of nutrients/other sub-
stances/foods/food components in agreement with
official nutrition recommendations. For generic
health claims it is desirable that they contribute to
a healthy diet on a population level. Claims
referring to improved performance (physical and
mental) and well-being may also be considered as
relevant and meaningful.
Selection of vitamins and minerals
With this background, health claims for vitamins
and minerals may be considered as relevant and
meaningful primarily for those of which a consider-
able part of the population has an intake lower than
recommended. For the SNF list, 25% was regarded
as a suitable limit to define ‘‘a considerable part of
the population’’. Accordingly, vitamins and miner-
als primarily selected were those of which 25% or
more of the population is estimated to have a lower
intake (14) than recommended in the Nordic
Nutrition Recommendations (NNR) (15). By this
procedure, vitamins A, B1 (thiamin), B2 (riboflavin),
C, D, E and folate, calcium, potassium, iron,
magnesium, selenium and zinc (men) were included,
while niacin, phosphorus, and vitamins B6 and B12
were excluded. A more liberal limit, corresponding
to 5% of the population having an intake below the
recommended intake would add also those four,
whereas setting the limit to 50% would exclude also
thiamin and magnesium.
Less than 25% of the population has a lower
intake of vitamin B12 than recommended. However,
claims regarding the connection between this vita-
min and ‘‘blood formation’’ and ‘‘normal nerve
function’’ were considered as relevant for vegans,
i.e. for people excluding all animal products from
their diet. Vitamin B12 was therefore added to the
list, with a remark that the wording of a B12 claim
should reflect that vegans are the main target group.
For vitamin A, the claim ‘‘Vitamin A is found in
visual pigments and is important for night vision.
Product X contains vitamin A’’ was listed in the
Swedish Code as an example of a scientifically true
claim that is irrelevant for Swedish conditions (8;
Appendix 1). Furthermore, the span within which
the intake is considered safe is smaller for vitamin A
than for other vitamins (15). Therefore, health
claims for foods high in vitamin A may lead to
overconsumption, especially if combined with sup-
plements. Vitamin A was therefore excluded.
Not all vitamins and minerals are included in the
dietary survey used as reference (14), e.g. iodine,
copper, biotin and pantothenic acid, and for these a
comparison of estimated and recommended intake
cannot therefore be made. Of these, only iodine is
included in the SNF list, since the intake of this
mineral relies on certain foods, particularly fortified
salt (15). In contrast, copper, biotin and pantothe-
nic acid are widely distributed in foods and
deficiency of these nutrients is generally not known
to occur.
Considerations for selected vitamins and minerals
In addition to the scientific basis, an important
consideration is what kind of claims regarding the
relevant nutrients can be regarded as meaningful to
and understandable by the average consumer. For
example, general claims for vitamins and minerals,
e.g. ‘‘needed for normal growth, normal reproduc-
tion, etc.’’, are by definition true for all essential
Bryngelsson S and Asp N-G
130nutrients. To claim such effects for single vitamins
or minerals is therefore less relevant, and may be
misleading. Vitamins and minerals are commonly
involved in many different functions in the body,
and for one single substance many claims may
therefore be scientifically true. However, one or a
few effects, considered as more important than the
others, can preferably be selected. Similarly, it
would be useful to consider the relative importance
of a specific vitamin or mineral for a certain effect,
in relation to other nutrients. Furthermore, for
functions affected by a large number of dietary
factors claims referring to one single nutrient may
be misleading. For example, unspecific claims
related to the immune system are therefore in
general questionable.
With this background, the following specific
considerations were made for the selection of claims
regarding vitamins and minerals for the SNF list.
Vitamin B2. Although claims such as ‘‘Riboflavin
contributes to the normal release of energy from
foods’’ and ‘‘Vitamin B2 contributes to the normal
transport and metabolism of iron in the body’’ are
scientifically true (16), they are hardly understand-
able by the consumer, and may even be misleading.
A claim related to healthy skin and mucous
membranes can also be regarded as having ques-
tionable consumer relevance. Therefore, no claim
was included in the SNF list regarding vitamin B2.
Vitamin D. The requirement for vitamin D (D3)
can be completely satisfied by solar exposure of the
skin. However, at the latitude of the Nordic
countries vitamin D deficiency may occur if the
diet is devoid of this vitamin (15). Vitamin D
contributes to calcium absorption from the intes-
tine, and is essential for the mineralization of the
skeleton. There are also indications that vitamin D
plays other roles, e.g. related to cancer, autoimmune
disease, infections and muscle strength, but such
effects cannot yet be regarded as well established.
Therefore, the connection between vitamin D and
bone health is prioritized for the Article 13.1 list.
Zinc. The claim ‘‘Zinc is needed for many of the
body’s enzyme systems’’ has, since the revision in
2004, been included in the Code as an example of
relevant nutrient function claims. However, as
discussed above it was considered questionable to
include such general claims for individual minerals.
Other scientifically true claims for zinc may refer to
effects on immune system, cell division and healthy
skin (16). However, all of these are very general and
therefore questionable, as discussed above. Claims
regarding the connection between zinc and normal
growth would refer to the development of children,
and relate to Article 14. No claim on zinc was
therefore included in the SNF list.
Iron and iodine. Claims such as ‘‘Iron/iodine is
necessary for normal neurological development of
embryos/foetus’’ may be scientifically true (16).
However, since this is not the main health issue
related to these minerals such claims were not
included in the SNF list.
Magnesium. Of the many functions of magnesium
in the body, one identified as important was a
possible beneficial effect on blood pressure. How-
ever, even though there is some epidemiological
support for a relation between low intake of
magnesium and hypertension it has not yet been
conclusively established that too low a dietary
intake of magnesium is any primary causative factor
for this outcome (15). The relative importance of
magnesium for effects on blood pressure is therefore
so far considered questionable, especially in relation
to other dietary factors (e.g. sodium) affecting
blood pressure.
Wording
A number of factors must be considered for
appropriate wording of health claims. The Regula-
tion highly stresses that health claims should be
understandable by the average consumer, but they
should also reflect the scientific basis and act as an
effective marketing tool. In addition, borderline
issues (e.g. Article 13 versus Article 14 claims and
health claims versus medicinal claims) must be
considered (see below), as well as the overall
impression in combination with other information
provided, on the packaging or elsewhere.
Wordings suggested in the SNF list aim to
illustrate what claims on the selected health rela-
tionships may look like. However, the wordings have
not been fully evaluated, and the suggested claims
should so far be considered as preliminary and
regarded as ‘‘type of claim’’, rather than suggestions
on the final and/or only wording allowed. At this
point there are still some question marks relating to
what wording will be considered appropriate to
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yet known whether there will be any distinction
among ‘‘necessary for’’, ‘‘helps to’’, ‘‘needed to’’
and ‘‘contributes to’’.
The two-step principle
The Swedish Code stresses that wordings of generic
claims should ensure that they are not perceived as
product specific, i.e. they must not indicate that the
particular product in question has a certain effect
on disease risk reduction. It would be especially
important to put such claims in the context of a
balanced diet. For this purpose, the two-step
principle was introduced in the Code, and required
for disease risk reduction claims (8). The two-step
principle means that (i) the connection between diet
and a physiological function/reduced risk of disease
and (ii) the product’s composition are given sepa-
rately, but in connection to each other. Although
also suggested for nutrient function claims in the
Code, this principle has not been applied in the SNF
list, but it should be noted that all examples in the
Codex Guidelines are worded according to the two-
step principle (13).
Conditions of use
The Code pinpoints that the amount of the food
product normally consumed must be such that it
has appreciable significance for a balanced diet, and
that the product’s composition must be such that it
is relevant to the claim. However, similarly to the
wording of claims, setting appropriate conditions is
a challenge. On the one hand, required levels of the
active substance should be high enough to guaran-
tee that the food product bearing the claim will
actually contribute to the effect claimed. If not, the
consumer may be misled. On the other hand, claims
may stimulate consumption of a range of fortified
products with risk of overconsumption, especially in
combination with food supplements.
In the Code, conditions of use were specified by
the last revision, in 2004 (8; Appendices 1 and 2).
For nutrient function claims for vitamins and
minerals, the general criterion is that the food
product shall be a ‘‘source of’’ the substance in
question, i.e. the food shall contain at least 15% of
the recommended daily intake (RDI) per 100g, as
specified by the Council Directive on nutrition
labelling for foodstuffs (17). Furthermore, normal
daily intake of the product shall provide at least
15% of RDI of the actual vitamin or mineral.
Whenever possible, the conditions of use to be
suggested in the SNF list will be similar to, or based
on the criteria specified within the Code. However,
for some claims the conditions in the SNF list have
to be slightly modified to comply with the condi-
tions for nutrition claims as specified in the Annex
of the Regulation (1).
References
For generic claims, the scientific body of evidence
should be the same as for official nutrition recom-
mendations, i.e. surveys such as the WHO TRS 916
report (18), the NNR (15), reports from the US
Institute of Medicine, Food and Nutrition Board
(19), and the forthcoming European Population
Reference Intakes (PRI). Such references are there-
fore primarily used for the SNF list, together with
selected reports published by JHCI and the US
Food and Drug Administration (FDA), e.g. for
vitamins and minerals (16), oats (20, 21), barley (22)
and wholegrain (23, 24). For the PFPs evaluated
and approved, which will also be suggested by SNF
for the national Article 13.1 list, the evaluation
reports (2534) and relevant studies referred therein
will be listed as references.
Some borderline issues
It is not yet known whether claims referring to
cholesterol level, blood pressure and a healthy heart
(e.g. ‘‘maintain a healthy level of/lowers choles-
terol’’, ‘‘maintain a healthy blood pressure/lowers
blood pressure’’ and ‘‘maintain a healthy heart’’)
will be accepted as Article 13 claims. There is a
possibility that such claims will be regarded as
implied reduction of disease risk claims and thereby
fall under Article 14. Claims related to ‘‘healthy
heart’’, or the like, may be considered too vague,
and therefore be acceptable only in combination
with a more specific claim, e.g. ‘‘helps to maintain a
healthy cholesterol level’’ (1; Article 10.3). In view
of these ongoing discussions, claims regarding both
cholesterol levels/blood pressure and heart health
are included in the SNF list.
Claims referring to the normal development of
embryos (e.g. for folate) may also be expressed as
normal pregnancy outcome, and regarded as claims
targeted at fertile women (primarily those planning
pregnancy) and thereby eligible for the Article 13.1
list, as suggested here. However, if considered as a
health claim referring to children’s growth and
development this claim would fall under Article 14.
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Some issues related to the Article 13.1 list, consid-
ered within the Code, are commented on below.
Glycaemic index claims
The concept of glycaemic index (GI) is a well-
defined way of ranking foods high in carbohydrates
owing to their effect on the blood glucose response.
Thus, ‘‘low GI’’ would be well defined once an
upper value for what is considered as ‘‘low’’ is set.
Within the Code this upper limit was set to 55, using
glucose as a reference (GI100) (8; Box 1). In the
Regulation, GI claims might be considered as
Article 13.1a claims, i.e. claims referring to the
role of a nutrient (carbohydrates) in the functions
of the body (blood glucose response). However,
since many factors, including food matrix and food
processing, influence the GI value of a food,
determinations in humans are required on each
product. Experiences from handling GI claims
within the Code strongly stress the importance of
consulting expertise for a standardized evaluation
of GI determinations. A premarketing evaluation
would be useful to avoid misleading GI claims, at
least until the methodology for GI determinations
has been further developed and harmonized.
Since specific health outcomes of a low GI food
or diet, e.g. reduced risk of a disease or beneficial
effects on a risk factor for disease, satiety or body
weight, have not been considered as well established
(35), no such claims are included in the SNF list.
Probiotic and prebiotic claims
The effects of probiotic bacteriavary among strains,
and even among species. There is, so far, no
scientific agreement on criteria for claims on effects
of probiotic bacteria in general (e.g. ‘‘Probiotic
bacteria stimulate a healthy flora of bacteria in
the intestine’’, ‘‘...promotes the balance of the
intestinal flora’’ or ‘‘...helps the body to protect
itself’’), although such general claims for probiotics
are frequently used on the market. Furthermore, the
effects of a specific strain/species may vary depend-
ing on, for example, the food matrix. Within the
Code, probiotic claims have therefore been consid-
ered as PFP, requiring scientific documentation on
the final product. Those evaluated and approved
within the Code will be suggested by SNF for the
national Article 13 list.
The Code includes a generic nutrient func-
tion claim for dietary fibre referring to ‘‘bowel
regularity’’. More specific claims on prebiotic
effects, e.g. ‘‘stimulates bifidobacteria’’ or ‘‘increases
calcium absorption’’ have not been scientifically
evaluated within the Code, and are therefore not
included in the SNF list.
Fruit and vegetables
Epidemiological studies suggest a connection be-
tween intake of fruit and vegetables and a reduced
risk of cardiovascular disease and certain types of
cancer (15), and there is a consensus that most
European consumers should increase their intake of
fruit and vegetables. According to WHO TRS 916,
the evidence for beneficial effects of increased intake
of fruit and vegetables (including berries) on
reduced risk of cardiovascular disease and obesity
is ‘‘convincing’’ (18). Within the Code a general
reference to the official recommendations from the
NFA of a daily intake of at least ½ kg fruit and
vegetables is suggested as useful in marketing and
labelling (8; Appendix 1). The possibility of making
more specific health claims for fruit and vegetables,
e.g. in relation to heart health, has been discussed,
but so far the scientific data have not been
considered conclusive enough for any decision.
Antioxidants
It is commonly suggested that the beneficial health
effect of fruit and vegetables can be explained, at
least partly, by their content of antioxidants. There
is also increasing interest in claiming that food
products are ‘‘high in antioxidants’’, based, for
example, on the relative total antioxidant capacity
of the product in question, compared with other
foods and measured by in vitro methods. Further-
more, in the final version of the Code claims on the
connection between certain vitamins, i.e. vitamin C,
vitamin E and beta-carotene (provitamin A), and
cell protection owing to antioxidant actions were
listed as examples of nutrient function claims (8).
However, in the light of the inconclusive results
from available intervention studies with specific
antioxidants, health claims for antioxidants may
be questionable for the time being. Furthermore,
there are no official nutritional recommendations
for dietary antioxidants (15). There are also insuffi-
cient data relating the in vitro determination of, for
example, total antioxidant capacity to health out-
comes. There are therefore several reasons to
question whether antioxidant claims are suitable
for the Article 13.1 list. An exception would be for
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certain endogenous enzymes exerting antioxidant
activity in cells (15).
Unsaturated fatty acids
It is well established that saturated fatty acids affect
levels of blood cholesterol negatively. Therefore, the
intake of these should be limited and for most
people reduced (15). A reduced intake of saturated
fatty acids may be achieved either by a decreased
total fat intake, or by exchanging saturated fatty
acids for unsaturated fatty acids. However, there is
less evidence that an increased intake of unsaturated
fatty acids per se would contribute substantially to a
beneficial effect on blood cholesterol. For most
consumers there are also good reasons not to
increase total fat intake, which may be a practical
consequence of promoting a higher proportion of
unsaturated fatty acids in the diet. Therefore, claims
on connections between fat quality and effects on
cholesterol levels should primarily focus on satu-
rated fatty acids.
Fish and omega-3 fatty acids
Available evidence strongly suggests that eating fish
is related to a reduced risk of fatal coronary heart
disease, and that this effect, at least partly, is
mediated by the long-chain omega-3 fatty acids in
fish (15). A main hypothesis today is that the
beneficial effect of long-chain omega-3 fatty acids
is mainly due to their antiarrhythmic effects, but
they may also contribute by positive effects on
triglycerides and blood pressure. It is also possible
that other constituents of fish, e.g. proteins, con-
tribute to abeneficial health effect. According to the
Code a generic claim on the connection between
long-chain omega-3 fatty acids from fish and heart
health has been allowed since 1997 (8). However,
more specific claims on long-chain omega-3 fatty
acids or claims for fish in general have not been
evaluated within the Code, and are therefore not
included in the SNF list.
Beans, lentils and legumes  low GI
Similarly to the case for pasta products, GI tables
indicate that beans, lentils and legumes in general
are low GI foods (36, 37), and there is a common
idea that those foods always give a low and slow
blood sugar response after a meal. However, it
is not yet well known how commercial food
processing commonly applied to these foods (e.g.
autoclaving) affects their GI. Therefore, it is con-
sidered premature to list a generic GI claim for these
foods.
Carbohydrates  physical performance
Dietary carbohydrates are essential for the recon-
stitution of the body’s glycogen reserves after
physical activity, for example, and extremely low
intake of carbohydrates will impair physical perfor-
mance (15). However, carbohydrates are present in
most foods consumed in a common diet, and it may
therefore be considered as a less relevant claim.
Claims referring to improved physical performance,
owing to improved carbohydrate composition or
other characteristics, would seem relevant primarily
for specific foods developed for and targeted at
athletes.
Dietary fibre  satiety and body weight
Several physiological effects of foods high in dietary
fibre, e.g. low energy density, may contribute to
body-weight management, and the evidence that
dietary fibre may protect against weight gain and
obesity has been graded as ‘‘convincing’’ (18).
However, the scientific support for a generic health
claim on the connection between dietary fibre and
satiety/body weight may be premature and has so
far not been evaluated within the Code. Therefore,
such claims are not included in the SNF list.
Concluding remarks
The Regulation highly stresses that health claims
shall be understandable by the average consumer,
but it is less clear to what extent consumer relevance
will be considered as an important factor when the
COM establishes a Community Register of ap-
proved claims. However, according to EFSA, the
evidence supporting health claims should demon-
strate the extent to which the claimed effect of the
food/food constituent is relevant for human health
(11). Such considerations would be in line with the
basic principles applied within the Code, and would
be helpful for the consumer. Selecting relevant and
meaningful claims is a delicate and challenging task
on a national level, and even more so on a European
level. A procedure for the selection of vitamins and
minerals to be prioritized to be on the Community
list, from a Swedish perspective, is suggested. This
procedure, and other standpoints taken here, are
based on the principles of the Swedish Code and the
practical experiences from handling health claims
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scientific evidence should be considered when
approving claims for the Article 13.1 list, or other
arguments for selection than those suggested here,
could be raised. However, even if not applied on a
regulatory basis, priorities as suggested here may
also be applied voluntarily by food business opera-
tors, with the aim of using health claims in a
responsible and sustainable manner. If a large
number of less relevant health claims were going
to be used in the labelling and marketing of food
products in the future, there would be a risk that
these would cover the more important claims, and
confuse the consumer. Such a situation would not
facilitate consumers’ trust in health claims, which
appears to be a prerequisite for the successful
achievement of the goals of the Regulation, and
for health claims to constitute useful marketing
tools in the long run.
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